106 related articles for article (PubMed ID: 9378179)
1. [Cost-benefit analysis of a mammography screening program extended to all the national territory].
Vanara F; Zappa M; Rosselli del Turco M; Segnan N; Paci E; Ponti A
Epidemiol Prev; 1997; 21(2):118-28. PubMed ID: 9378179
[TBL] [Abstract][Full Text] [Related]
2. [Cost analysis of a mammographic screening program].
Vanara F; Ponti A; Frigerio A; Segnan N
Epidemiol Prev; 1995 Dec; 19(65):318-29. PubMed ID: 8852081
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of mammography screening for breast cancer in a low socioeconomic group of Iranian women.
Barfar E; Rashidian A; Hosseini H; Nosratnejad S; Barooti E; Zendehdel K
Arch Iran Med; 2014 Apr; 17(4):241-5. PubMed ID: 24724599
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
5. Benefits and costs of screening and treatment for early breast cancer. Development of a basic benefit package.
Kattlove H; Liberati A; Keeler E; Brook RH
JAMA; 1995 Jan; 273(2):142-8. PubMed ID: 7799495
[TBL] [Abstract][Full Text] [Related]
6. [Health economics analysis of breast cancer screening].
Boncz I; Sebestyén A; Gulácsi L; Pál M; Dózsa C
Magy Onkol; 2003; 47(2):149-54. PubMed ID: 12975661
[TBL] [Abstract][Full Text] [Related]
7. [Economic evaluation of the new national breast cancer screening programme in France: application to the Bouche-du-Rhone district].
Giorgi R; Reynaud J; Wait S; Seradour B
Bull Cancer; 2005 Nov; 92(11):995-1001. PubMed ID: 16316834
[TBL] [Abstract][Full Text] [Related]
8. Economic evaluation of diagnostic follow-up after primary treatment for breast cancer. Results of the Working Group on Economic-Organizational Aspects of Follow-up.
Mapelli V; Dirindin N; Grilli R
Ann Oncol; 1995; 6 Suppl 2():61-4. PubMed ID: 8547201
[TBL] [Abstract][Full Text] [Related]
9. A cost utility analysis of mammography screening in Australia.
Hall J; Gerard K; Salkeld G; Richardson J
Soc Sci Med; 1992 May; 34(9):993-1004. PubMed ID: 1631612
[TBL] [Abstract][Full Text] [Related]
10. Performance goals for an adjunct diagnostic test to reduce unnecessary biopsies after screening mammography: analysis of costs, benefits, and consequences.
Lee CI; Bensink ME; Berry K; Musa Z; Bodnar C; Dann R; Jarvik JG; Lehman CD; Ramsey SD
J Am Coll Radiol; 2013 Dec; 10(12):924-30. PubMed ID: 24295942
[TBL] [Abstract][Full Text] [Related]
11. The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand.
Szeto KL; Devlin NJ
Health Policy; 1996 Nov; 38(2):101-15. PubMed ID: 10160378
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of interventions to enhance mammography compliance using computer modeling (CAN*TROL).
Wu JH; Fung MC; Chan W; Lairson DR
Value Health; 2004; 7(2):175-85. PubMed ID: 15164807
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of nationwide breast carcinoma screening in Finland, 1987-1992.
Leivo T; Sintonen H; Tuominen R; Hakama M; Pukkala E; Heinonen OP
Cancer; 1999 Aug; 86(4):638-46. PubMed ID: 10440691
[TBL] [Abstract][Full Text] [Related]
14. Will early detection of breast cancer reduce the costs of treatment?
Salkeld G; Gerard K
Aust J Public Health; 1994 Dec; 18(4):388-93. PubMed ID: 7718652
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer screening by mammography in Norway. Is it cost-effective?
Norum J
Ann Oncol; 1999 Feb; 10(2):197-203. PubMed ID: 10093689
[TBL] [Abstract][Full Text] [Related]
16. Lower recurrence risk through mammographic screening reduces breast cancer treatment costs.
Kauhava L; Immonen-Räihä P; Parvinen I; Holli K; Pylkkänen L; Kaljonen A; Helenius H; Kronqvist P; Klemi PJ
Breast; 2008 Dec; 17(6):550-4. PubMed ID: 18922695
[TBL] [Abstract][Full Text] [Related]
17. [Cost-effectiveness of mammography screening in Norway].
Kåresen R; Bø JK; Haustveit S; Hervik A; Thoresen SO
Tidsskr Nor Laegeforen; 1999 Oct; 119(24):3553-9. PubMed ID: 10563171
[TBL] [Abstract][Full Text] [Related]
18. Effect of screening for cancer in the Nordic countries on deaths, cost and quality of life up to the year 2017.
Hristova L; Hakama M
Acta Oncol; 1997; 36 Suppl 9():1-60. PubMed ID: 9143316
[TBL] [Abstract][Full Text] [Related]
19. Measurement of the costs in two mammographic screening programmes in the province of Florence, Italy.
Zappa M; Spagnolo G; Ciatto S; Giorgi D; Paci E; Rosseli del Turco M
J Med Screen; 1995; 2(4):191-4. PubMed ID: 8719147
[TBL] [Abstract][Full Text] [Related]
20. Screening mammography in women aged 40-49 years: analysis of cost-effectiveness.
Rosenquist CJ; Lindfors KK
Radiology; 1994 Jun; 191(3):647-50. PubMed ID: 8184041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
